BRIEF published on 05/21/2024 at 12:12, 6 months 2 days ago Nombre d'actions et de droits de vote de Guerbet au 30 avril 2024 Droits De Vote Capital Social Actions Transparence Guerbet
PRESS RELEASE published on 05/21/2024 at 12:07, 6 months 2 days ago GUERBET : Nombre d'actions et de droits de vote composant le capital de la société au 30 avril 2024 Déclaration relative au nombre de droits de vote et d'actions composant le capital de la société conformément à la réglementation en vigueur Déclaration Droits De Vote Capital Social Actions Réglementation
BRIEF published on 03/20/2024 at 18:05, 8 months 3 days ago Important Changes to the Guerbet Board of Directors Board Of Directors Pharmaceutical Guerbet Medical Imaging Hugues Lecat
BRIEF published on 03/20/2024 at 18:05, 8 months 3 days ago Changements Importants au Conseil d'Administration de Guerbet Conseil D'administration Guerbet Imagerie Médicale Hugues Lecat Pharmaceutique
PRESS RELEASE published on 03/20/2024 at 18:00, 8 months 3 days ago Guerbet: Change in Guerbet’s Board of Directors. Guerbet appoints Hugues Lecat as a non-voting director with plans for him to become Chairman, enhancing the company's governance and strategic vision for future success Board Of Directors Guerbet Medical Imaging Chairman Appointment Hugues Lecat
PRESS RELEASE published on 03/20/2024 at 18:00, 8 months 3 days ago Guerbet: Evolution du Conseil d’Administration de Guerbet. Annonce de l'évolution du Conseil d'Administration de Guerbet avec la nomination de Hugues Lecat en qualité de censeur et futur Président, et déclarations des principaux intéressés Assemblée Générale Conseil D'administration Guerbet Imagerie Médicale Hugues Lecat
BRIEF published on 03/20/2024 at 17:50, 8 months 3 days ago Guerbet Announces Solid Growth and Improved Profitability in 2023 Full-Year Results Financial Results Profitability Guerbet Healthcare Imaging 2023 Growth
BRIEF published on 03/20/2024 at 17:50, 8 months 3 days ago Guerbet annonce une croissance solide et une rentabilité améliorée pour ses résultats annuels 2023 Résultats Financiers Rentabilité Guerbet Imagerie Médicale Croissance 2023
PRESS RELEASE published on 03/20/2024 at 17:45, 8 months 3 days ago Guerbet: 2023 full-year results. Guerbet publishes solid 2023 full-year results with revenue growth of 5.9% at CER and EBITDA margin exceeding target. Confirms outlook for 2024 with revenue growth > 8% and higher profitability Revenue Growth 2024 Outlook EBITDA Margin Guerbet 2023 Full-year Results
PRESS RELEASE published on 03/20/2024 at 17:45, 8 months 3 days ago Guerbet: Résultats annuels 2023. Publication des résultats annuels 2023 de Guerbet avec une croissance solide de l’activité et une rentabilité supérieure aux objectifs. Perspectives 2024 confirmées avec prévisions de croissance et rentabilité en hausse Croissance Perspectives 2024 Guerbet Résultats Annuels Rentabilité
Published on 11/22/2024 at 23:55, 1 day 1 hour ago Boron One Announces Early Warrant Exercise Incentive Program
Published on 11/22/2024 at 23:30, 1 day 1 hour ago Electric Royalties Enters Into Definitive Agreement to Acquire 0.75% Gross Revenue Royalty on Producing Punitaqui Copper Mine in Chile
Published on 11/22/2024 at 23:05, 1 day 2 hours ago Nexa Resources Announces Closing Transaction of Pukaqaqa Project Sale to Olympic
Published on 11/22/2024 at 22:30, 1 day 2 hours ago Delaforce Energy Corp. Announces Acquisition of Bouchard Well Service Ltd.
Published on 11/22/2024 at 18:14, 1 day 7 hours ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 11/22/2024 at 17:53, 1 day 7 hours ago Funding Circle Plc: POS-Transaction in Own Shares
Published on 11/22/2024 at 16:55, 1 day 8 hours ago EQS-Adhoc: Comment on withdrawn non-binding offer
Published on 11/22/2024 at 16:15, 1 day 9 hours ago NRJ GROUP - Le Conseil d'Etat rejette le recours de NRJ 12 et NRJ GROUP
Published on 11/21/2024 at 06:58, 2 days 18 hours ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
